Displaying 11 - 20 of 590
Image
Understanding polycythemia vera (PV): Diagnosis, treatments and follow-up care - myeloproliferative neoplasms (MPN) conference 2025
Updated:
In this 1-hour live webcast, Dr. Sonia Cerquozzi, hematologist at the Tom Baker Cancer Center and Peter Lougheed Centre in Calgary, reviews PV, a type of MPN - its diagnosis, treatment options and aspects of follow-up care.
Myeloproliferative neoplasms
How we decide which projects to fund
Updated:
Learn more about our scientific review panels and medical and scientific advisory committee.
Essential thrombocythemia (ET)
Updated:
Learn more about essential thrombocythemia (ET) and the resources we have available.
Myeloproliferative neoplasms
Image
Understanding essential thrombocythemia (ET): Diagnosis, treatments and follow-up care: MPN conference 2025
Updated:
In this 1-hour webcast, Dr. Lynda Foltz, University of British Columbia, will review this type of myeloproliferative neoplasm (MPN): its diagnosis, treatment options, and aspects of follow-up care.) People with ET have too many platelets, a type of blood cell. Too many…
Myeloproliferative neoplasms
Myelofibrosis (MF)
Updated:
Learn more about myelofibrosis (MF) and the resources we have available.
Myeloproliferative neoplasms
Understanding insurance and organizing finances
Updated:
When it comes to your personal finances, even with health insurance, cancer treatment can have an impact for you and your family. Most aspects of your cancer care will be covered by your provincial health insurance, but there are exceptions depending on where you live in Canada.
One Kilometre at a Time transportation subsidy program
Updated:
The One Kilometre at a Time transportation subsidy from the Leukemia and Lymphoma Society of Canada provides one-time financial support to Canadians with an acute or chronic blood cancer requiring at least 30 km round trip for medical appointment(s) as referred by their…
Addressing the global Pegasys® shortage
Updated:
The Leukemia & Lymphoma Society of Canada and the Canadian MPN Network have been working alongside clinicians, pharmaceutical manufacturers and Health Canada to find a solution for Canadians who are impacted by myeloproliferative neoplasms (MPN).
Advocacy, Partners, Myeloproliferative neoplasms
Image
Évolution des thérapies dans la myélofibrose (MF) : Amélioration des traitements et de la prise en charge
Updated:
Dans cette webdiffusion, le Dr Pierre Villeneuve, hématologue à l’Hôpital d’Ottawa, a passé en revue la MF et l’évolution au fil du temps du diagnostic, des options de traitement et des aspects des soins de suivi.
Myeloproliferative neoplasms
Ezra Dyck
Updated:
Ezra Dyck, of northern Alberta, now 8, was diagnosed with T-cell Acute Lymphoblastic Leukemia (ALL) at the age of 5. This is his story of blood cancer treatment and recovery told by his mom Kristin Dyck.